Advancing the Use of Cancer Vaccines in Glioblastoma to Reprogram the Patient’s Immune System

• Designing vaccines to prime and activate the patient’s own immune system to recognize and attack specific GBM cells
• Identifying and utilizing GBM specific tumor antigens to develop targeted and effective vaccine strategies
• Focussing on GBM vaccines in combination with other modalities to overcome the TME and boost anti-tumor response

Speakers:

Saskia Biskup

Managing Director

CeGaT GmbH